rapid commercial software platform (iSchemaView)
90
Structured Review
iSchemaView
rapid commercial software platform
Rapid Commercial Software Platform, supplied by iSchemaView, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rapid+software+platform/rapid+software+platform/10__1161_slash_jaha__124__034581-63-14-15
Average 90 stars, based on 1 article reviews
Rapid Commercial Software Platform, supplied by iSchemaView, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rapid+software+platform/rapid+software+platform/10__1161_slash_jaha__124__034581-63-14-15
Average 90 stars, based on 1 article reviews
rapid commercial software platform - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Automated CT Perfusion Imaging Versus Non-contrast CT for Ischemic Core Assessment in Large Vessel Occlusion. Article Snippet: Purpose There is increasing use of automated computed tomography perfusion (CTP) to aid thrombectomy decision in emergent large vessel occlusion.. It is important to understand the performance of these software packages in predicting ischemic core and tissue-at-risk in the real-world setting.. The aim of this study was to evaluate whether ischemic core on non-contrast CT (NCCT) and automated CTP correspond and predict infarct extent after thrombectomy for ischemic stroke. Article Title: The Relative Cerebral Blood Volume (rCBV) < 42% Is Independently Associated with Collateral Status in Anterior Circulation Large Vessel Occlusion Article Snippet: The RAPID ( Software:Article Title: Collateral Effect of Covid-19 on Stroke Evaluation in the United States Article Snippet: .. DOI: 10.1056/NEJMc2005396 Collateral Effect of Covid-19 on Stroke Evaluation in the United States To the Editor: The effect of the Covid-19 pandemic on medical care for conditions other than Covid-19 has been difficult to quantify.1 Any decrease in care for patients with acute conditions such as ischemic stroke may be consequential because timely treatment may decrease the incidence of disability.2-4 We used the numbers of patients in a commercial neuroimaging database associated with the Article Title: Characteristics and Comparison of 32 COVID-19 and Non-COVID-19 Ischemic Strokes and Historical Stroke Patients Article Snippet: .. A recent report captured the rates of utilizing Article Title: Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging Article Snippet: .. The Article Title: Association of Coronavirus Disease 2019 and Stroke: A Rising Concern Article Snippet: .. Recently, there has been 39% decrease in the timeliness of people receiving acute stroke evaluations based on a review of neuroimaging databases from the |